Skip to main content

Table 5 Occurrence of every regions with low susceptibility to antibiotics in major blood-borne pathogens (%)

From: Antimicrobial susceptibility among gram-positive and gram-negative blood-borne pathogens collected between 2012-2016 as part of the Tigecycline Evaluation and Surveillance Trial

bacterial number of antibioticsa × 2 Africa Asia Europe North America Latin America
E. coli 14 7 (50.0) 4 (28.6) 0 (0.0) 0 (0.0) 3 (14.3)
K .pneumoniae 16 8 (50.0) 0 (0.0) 3 (18.8) 0 (0.0) 5 (31.3)
S. marcescens 6 2 (33.1) 1 (16.7) 0 (0.0) 2 (33.3) 1 (16.7)
E. cloacae 16 5 (31.3) 6 (37.5) 2 (12.5) 0 (0.0) 3 (18.8)
P. aeruginosa 10 1 (10.0) 3 (30.0) 4 (40.0) 0 (0.0) 2 (20.0)
A. baumannii 16 7 (43.8) 1 (6.3) 1 (6.3) 0 (0.0) 7 (43.8)
S. aureus 4 2 (50.0) 2 (50.0) 0 (0.0) 0 (0.0) 0 (0.0)
E. faecalis 4 2 (50.0) 0 (25.0) 1 (25.0) 1 (25.0) 0 (0.0)
E. faecium 11b 2b(18.2) 2 (18.2) 2b(18.2) 2 (18.2) 3 (27.3)
S. pneumoniae 14 2 (14.3) 7 (50.0) 0 (0.0) 2 (14.3) 3 (21.4)
Total 111 38 (34.2) 26 (23.4) 13 (11.7) 7 (6.3) 27 (24.3)
  1. a There were antibiotics with a global susceptibility of less than 90%
  2. b Same susceptibility in Africa and Europe of ampicillin to E. faecium